Chris Shibutani analyst GOLDMAN SACHS

Currently out of the existing stock ratings of Chris Shibutani, 66 are a BUY (52.8%), 54 are a HOLD (43.2%), 5 are a SELL (4%).

Chris Shibutani

Work Performance Price Targets & Ratings Chart

Analyst Chris Shibutani works at GOLDMAN SACHS with a stock forecast success ratio of 48.96% fulfilled within 97.27 days on average. Previously, Chris Shibutani worked at GOLDMAN.

Chris Shibutani’s has documented 244 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RVNC, Revance The at 13-May-2024.

Wall Street Analyst Chris Shibutani

Analyst best performing recommendations are on RXDX (PROMETHEUS BIOSCIENCES).
The best stock recommendation documented was for RXDX (PROMETHEUS BIOSCIENCES) at 12/7/2022. The price target of $117 was fulfilled within 1 day with a profit of $21.2 (22.13%) receiving and performance score of 221.29.

Average potential price target upside

ALKS Alkermes Plc BNTX BioNTech SE JNJ Johnson & Johnson MCRB Seres Therapeutics NBIX Neurocrine Biosciences NKTR Nektar Therapeutics PBYI Puma Biotechnology RVMD Revolution Medicines TNGX Tango Therapeutics UTHR United Therapeutics ABBV AbbVie BMY Bristol-Myers Squibb Company LLY Eli Lilly and Company PFE Pfizer AMLX Amylyx Pharmaceuticals EXAI Exscientia Ltd ADR TRDA Entrada Therapeutics EQRX EQRx RPRX Royalty Pharma Plc KYMR Kymera Therapeutics INVA Innoviva RXDX Prometheus Biosciences ERAS Erasca MDCO The Medicines Company RPTX Repare Therapeutics RVNC Revance The SDGR Schrodinger SNDX Syndax Pharmaceuticals OGN Organon ARQT Arcutis Biotherapeutics 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

35

$10.98 (45.71%)

35

24 days ago

13/17 (76.47%)

$11.14 (46.69%)

244

Buy

39

$14.98 (62.36%)

39

1 months 25 days ago

3/7 (42.86%)

$11.76 (43.17%)

101

Sell

25

$0.98 (4.08%)

31

3 months 6 days ago

2/2 (100%)

$-5.39 (-17.74%)

86

Hold

33

$8.98 (37.39%)

33

6 months 6 days ago

3/4 (75%)

$8.82 (36.48%)

32

Buy

35

$10.98 (45.71%)

37

7 months ago

17/33 (51.52%)

$10.3 (41.70%)

172

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Chris Shibutani is most bullish on?

Potential upside of $23.38 has been obtained for RPRX (ROYALTY PHARMA PLC)

Which stock is Chris Shibutani is most reserved on?

Potential downside of -$84.43 has been obtained for LLY (ELI LILLY AND COMPANY)

What Year was the first public recommendation made by Chris Shibutani?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?